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Methods: We have analyzed donor bile ducts taken 1 hour after portal and ar-
terial graft recirculation in order to assess bile duct damage caused by preser-
vation and recirculation. Bile duct tissue specimens of 36 donors were fixed in
PBS-buffered formalin and processed according to standard protocols.
Results: Loss of epithelium of the bile duct being complete in 17% was a
common feature in all specimens. The majority of cases (87%) showed dif-
fuse transmural bleeding of the bile. Inflammation was generally only sparsely
detected. The most remarkable alterations were observed in the arterioles:
In 36% of cases, we found damage of the endothelial lining characterized by
loss of endothelial cells and sub-endothelial edema. Additionally, 47% of the
specimens revealed variable numbers of necrotic arterioles. In these patients,
necrotic walls of the bile ducts occurred (with a total number of 20 donors).
Vessels with thrombi could be detected in 42% of the specimens.
Conclusions: To our knowledge, this is the first study analyzing the histology
of donor bile ducts immediately after recirculation during LT. The most promi-
nent finding was a remarkable vascular damage leading to arteriolonecrosis.
Further studies should elucidate if these lesions are caused by inadequate
preservation or by natural variations of the blood supply to the bile ducts.
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Background: Wider utilization of liver grafts from donors !70 yo could sub-
stantially expand the donor pool, but their use remains limited by fear of their
poor outcome. We examined the results of liver transplantation (LTx) using
livers from donors !70 yo at our center.
Methods: From February 2003 to August 2010, 450 LTx were performed. Of
those 58 (13%) were performed using donors !70 yo. Their outcome was
compared to that of LTx using donors <70 yo.
Results: Cerebrovascular causes of death predominated in donors !70 yo
(85% versus 47% in donors <70 yo) (p<0,001) whereas traumatic causes of
death predominated in donors <70 yo (36% versus 14% in donors !70 yo)
(p=0,002). Unlike grafts/donors <70 yo, older grafts/donors had no additional
risk factor (steatosis, high sodium, hemodynamic instability). Both groups were
comparable for cold and warm ischemia times. No difference was noted in
posttransplant peak transaminase, incidence of primary non-function, hep-
atic artery thrombosis, biliary strictures, and retransplantation between both
groups. The 1 and 5-year patient survival were 90% and 80% in recipients of
livers <70 yo versus 88% and 80% in recipients of livers !70 yo (p=0,74).
Recipients of older grafts were 9 years older than recipients of younger grafts
(p<0,001) and tended to have a lower laboratory MELD score (p=0,074).
Conclusion: Short and middle-term survival following LTx with donors !70
yo can be excellent providing that donors and recipients are adequately se-
lected. Septuagenarian and octogenarian victims of cerebrovascular ischemia
and bleeding represent a large pool of potential donors whose wider use could
substantially reduce the mortality on the waiting list.
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Unlike Maastricht type 3 donation after cardiac death (DCD) donors, in whom
cardiac arrest (CA) is induced by the removal of life support, type 2 donors ar-
rest unexpectedly, typically outside the hospital. These donors have significant
potential to expand the donor pool (US Institute of Medicine, 2006).
Aim: Analyze the results of type 2 DCD livers used for transplant as well as all
potential liver donors treated under our center’s type 2 DCD protocol.
Methods: Cardiac arrest was extrahospitalary. Potential donors arrived with
cardiorespiratory support (CRS). Death was declared and femoral vessels
canulated to establish normothermic extracorporeal membrane oxygenation
(NECMO), which was maintained until organ recovery.
Results: From 4/02 to 12/10, there were 400 activations of our type 2 DCD
protocol; 34 liver transplants were performed (9%). Causes for rejecting a
type 2 DCD liver were classified as absolute or relative, the latter including
a prolonged phase (CA >15 min, CRS >150 min, NECMO > 4 hours), high
AST/ALT during NECMO, and poor macroscopic liver aspect at recovery. Over-
all, 130 livers (33%) were turned down due to relative contraindications.
Among transplanted livers, median follow-up was 24 months (range 0-111).
One-year graft and patient survival rates were 71% and 82%, respectively.
Ischemic cholangiopathy developed in three patients (8%), who were retrans-
planted at 5, 8, and 13 months.
Comment: This is largest series of type 2 DCD liver transplants to date. Based
on protocol activations, the applicability of type 2 DCD liver transplant was less
than 10%. Thirty three percent of livers were turned down based on relative
contraindications. It is possible that with better means of preservation ex vivo,
such as normothermic machine perfusion, we may be able to improve the via-
bility of these grafts and improve the applicability of this procedure.
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Introduction: The Belgian experience with DCD liver transplantation (LT) was
retrospectively updated with the aim to evaluate patient and graft survivals,
and biliary complications.
Patients and methods: From 2003 to 2009, 111 DCD-LTs have been per-
formed in Belgium. The characteristics of donors, recipients, transplantation
procedure and outcomes were retrospectively reviewed.
Results: Mean donor age was 47.6±15.5 years (range: 13-79). Donor causes
of death were anoxia (26.1%), head trauma (31.5%), stroke (36%) and eu-
thanasia (5.4%). Mean duration of treatment withdrawal to aortic cold perfu-
sion was 24.4±13 min, mean cold ischemia time (CIT) was 367.3±128.9 min.
Mean recipient age was 55.9±11.2 years (range: 10-73). The most frequent in-
dications for LT were cirrhosis (49.5%) and hepatocellular carcinoma (39.6%).
The rate of primary non function was 4.5%. Overall patient and graft survival
was 88% and 80% at 1 year, 75% and 65% at 3 years, respectively. Thirty-
seven patients (33.3%) developed biliary complications with the need for endo-
scopic or surgical management in twenty-eight and retransplantation in seven.
In univariate analysis, HU indication, younger donor age, elevated donor biliru-
bin level, absence of heparin administration to the donor, CIT, secondary WIT
(liver implantation), were significantly (p<0.05) associated with transplant fail-
ure. Risk factors for biliary complications were short donor ICU stay, elevated
donor bilirubin level, long duration between switch off to cold perfusion, long
CIT, while local allocation decreased the risk. In multivariate analysis, elevated
donor bilirubin level and duration of donor hepatectomy were associated with
transplant failure while higher donor bilirubin level, CIT and Meld score were
associated with occurrence of biliary complications.
Conclusions: In an era of organ shortage, DCD transplantation is a valuable
treatment option with an adequate selection of donors and recipients.
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Background: Shortage of available organs is a limiting factor in liver trans-
plantation (LT). The use of donors after cardiac death (DCD) offers potentials
to increase the organ pool. The early results with DCD liver grafts were associ-
ated with a greater incidence of non-anastomotic biliary complications, leading
to several programs to abandoning this source of organs. The UNOS data
